Stakeholder Segment | Expected Benefits |
Service Providers | • Enable seamless technological solutions for the research use of EHR-health data • Build and grow a profitable and sustainable business landscape • Leverage new business opportunities |
Clinical Trial Sponsors (pharmaceutical industry, CROs, CRUs) | • Enhance the efficiency of clinical trial processes • Reduce the time and costs of bringing new drugs to market • Generate added value |
Hospitals, Clinical Research Centers, Clinical Investigators | • Participate in more clinical research programs • Improve health data quality • Enhance health care pathways • Increase research activities and revenues |
ICT Industry (EHR/EDC vendors) | • Provide EHR solutions that will support interoperable clinical data capture and exchange • Develop business channels • Grow existing market |
Patients | • Benefit from more patient-centered clinical trials • Gain access to safe and effective medicines, towards improving health outcomes and safeguarding patient safety |
Regulatory Bodies, Health Technology Assessors | • Generate high quality clinical efficacy, safety, cost-effectiveness and comparative effectiveness evidence • Support decision-making (marketing authorization, reimbursement recommendations) |
Health Authorities, Health Care Planners, Governments | • Enhance health policies, public health programs and decisions for optimizing health care delivery and patient outcomes |
European Clinical Research Market | • Attract more R&D investments in Europe |